Merck KGaA Expects Core Franchises, Alliances To Strengthen In China
Executive Summary
Merck KGaA's healthcare business in China will continue to center around its fertility, general medicines and endocrinology therapies while also building on new corporate alliances there, the German conglomerate’s global operations head told Scrip.